Virtual Reality for Sickle Cell Crisis

(RELIEVE-SCD Trial)

SL
RC
Overseen ByRose Corcoran
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Maryland, Baltimore
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This pilot study will evaluate the feasibility, tolerability, and preliminary analgesic effect of headset-based virtual reality interventions for adults with sickle cell disease experiencing vaso-occlusive crisis treated in an infusion center. Participants will be enrolled during routine outpatient sickle cell clinic visits and may receive study interventions during future qualifying infusion center visits for vaso-occlusive pain. Using a randomized, two-period crossover design, each participant will be assigned to receive two of three headset-based conditions across separate visits: sham 2D headset control, passive immersive 3D virtual reality, or active immersive interactive 3D virtual reality. The primary outcome is pain burden during the first 60 minutes after intervention start, measured as area under the curve of 0-10 numeric rating scale pain scores. Secondary outcomes include feasibility of intervention delivery, headset tolerability, pain at 120 minutes, opioid use, and participant-reported immersion and acceptability.

Who Is on the Research Team?

RG

Richard G Wilkerson, MD

Principal Investigator

Unversity of Maryland School of Medicine

Are You a Good Fit for This Trial?

This trial is for adults with sickle cell disease who are experiencing a pain crisis and are being treated at an infusion center. Participants must be able to use a headset device during their visit.

Inclusion Criteria

Receiving treatment from the Stoler Infusion center
My treatment plan includes IV opioids for acute pain.
I have a history of sickle cell disease.
See 1 more

Exclusion Criteria

Prior enrollment in this study
Known to be pregnant
Incarcerated at the time of evaluation
See 6 more

What Are the Treatments Tested in This Trial?

Interventions

  • Active Immersive Interactive 3D Virtual Reality
  • Passive Immersive 3D Virtual Reality

Trial Overview

The study tests three types of headset experiences: a basic (sham) 2D video, passive immersive 3D virtual reality, and active interactive 3D virtual reality. Each participant tries two different options in random order across separate visits.

How Is the Trial Designed?

6

Treatment groups

Experimental Treatment

Group I: Sham 2D, then Passive 3D VRExperimental Treatment2 Interventions
Group II: Sham 2D → Active 3D VRExperimental Treatment2 Interventions
Group III: Passive 3D VR → Sham 2DExperimental Treatment2 Interventions
Group IV: Passive 3D VR → Active 3D VRExperimental Treatment2 Interventions
Group V: Active 3D VR → Sham 2DExperimental Treatment2 Interventions
Group VI: Active 3D VR → Passive 3D VRExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Maryland, Baltimore

Lead Sponsor

Trials
729
Recruited
540,000+